Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Implantica Launches RefluxStop™ in Italy
Implantica, a medtech company at the forefront of bringing advanced technology into the body, announces […]
Granular Therapeutics to Accelerate Development of Next-Generation Pipeline for Treating Mast Cell Driven Diseases
Granular Therapeutics, a private biotech company specialising in precision biologic therapies for treating mast cell […]
Xeris Biopharma Appoints Ricki Fairley to Board of Directors
Xeris Biopharma, a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing […]
AskBio to Present Phase 1b Results Investigating AB-1005 as Treatment for Parkinson's Disease
Asklepios BioPharmaceutical (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary […]
New Imaging Method for Evaluating Transport of Oxygen to Blood Cells
In cooperation with Perimed AB, researchers from the Department of Biomedical Engineering at Linköping University, […]
Hansa Biopharma Announces Positive Reimbursement in Spain for Idefirix as Desensitization Treatment for Patients in Kidney Transplantation
Hansa Biopharma, a pioneer in enzyme technology for rare immunological conditions, has announced that the […]
Coeptis Therapeutics Secures Exclusive Rights to Negotiate the Acquisition of Transformational Cell Therapy Platform
Coeptis Therapeutics, a biopharmaceutical company developing innovative cell therapy platforms for cancer, announced it has […]
SamaCare Partners with AmerisourceBergen to Offer Prior Authorization Platform to Specialty Practices
SamaCare, a prior authorization platform for physician-administered medications, today announced a partnership with AmerisourceBergen Specialty […]
Lucy Therapeutics Appoints Neuroscience Drug Discovery and Development Expert Christopher J. Winrow, Ph.D., as Chief Scientific Officer
Lucy Therapeutics, a private biotech company developing proprietary mitochondrial-based small molecule therapies and biomarkers for […]
BGI Genomics Partners with Zentya to Launch Fecal DNA Test for Colorectal Cancer in Slovakia
BGI Genomics is pleased to announce the launch of COLOTECTTM 1.0 in Slovakia, in collaboration […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more